Close

A VERTICALLY INTEGRATED COMPANY

IBI, IBIGEN group, is a company that has been producing and selling injectable products all over the world for 100 years. It is also present in hospitals (Parental Products for Hospitals). Expert in aseptic dosing and ß-lactam products, it is a vertical company working from the raw material through the finished product to sales distribution and the patient’s bed.

FOCUS ON ANTIBIOTIC TREATMENTS

IBI has a long tradition and is specialized in the production of injectable sterile penicillin, which it exports all over the world. The IBI line of antibiotics includes various other products belonging to the classes of cephalosporins, quinolones, aminoglycosides and lincosamides.

Enter

FOCUS ON GASTRONENTEROLOGY

IBI is present in gastroenterology, since the 1970s, with products for therapy related to abdominal pathology, such as dyspepsia, cholelithiasis, cholestasis and other chronic hepatopathies such as steatosis and Non-Alcoholic Liver Disease (NAFLD), to the treatment of gastrointestinal symptoms with products for the improvement of peristalsis, meteorism and constipation.

Enter

OPEN INNOVATION

IBI has always been committed to the discovery, development and sale of innovative products and is now concentrated on the industry 4.0 challenge. In Europe it is a partner in the development of new therapy protocols, such as the EU nanomedicine project B-SMART, and it offers its experience to research centres and universities to create complex drugs and innovative therapies.

Enter
Export<br> 20 countries

Export
20 countries

300 employers<br>4 branches

300 employers
4 branches

18.000 mq<br>production plant

18.000 mq
production plant

AIFA, FDA, EDQM, TGA
certificates

Scientific tradition and innovation

IBI, IBIGEN Group, produces cGMP penicillins in oral and injectable forms. The continuous research and innovative technologies make the company an excellence in Italian pharmaceuticals and place it amongst the top 10 Italian companies in the production of various molecules for third party.

Enter

Export

Enter

Hospitals

Hospital in Italy    Hospitals in Germany    Hospitals in United Kingdom

Pharmacy

Enter

Latest news

undefined

Scuola-lavoro in campo 30 big del farmaceutico

Read all
undefined

REVER3MAB: "An ambitious project for the development of an innovative biological drug"?

IBI collaborates in the development of an innovative biological drug to revert resistance to conventional cancer treatments: project: REVER3MAB (EU, State and Region)

Read all
undefined

Seguiamo i farmaci fino a voi

Cinquanta milioni di investimento digitale e un forte impegno nella tracciabilità dei prodotti

Read all

See all news items

Thank you

We sent you an email. To activate the newsletter click on the link you will find in the message, thank you!

Sign up for the newsletter

Dichiarazione in merito al GDPR (Regolamento Generale Protezione dei Dati)

In caso di sottoscrizione Newsletter dovrai confermare l’iscrizione per mezzo di mail di conferma inviata all’indirizzo inserito. In tal caso il trattamento prevede:

la profilazione dell’utente in gruppi, status, preferenze secondo quanto indicato e dedotto dalle informazioni inviate tramite il form o successiva autonoma profilazione.
l’utilizzo del dato per l’invio di comunicazione a mezzo digitale (email, whatsapp) e non (cartaceo) avente scopo informativo/commerciale.
l'utilizzo della mail per la generazione di campagne marketing e informative personalizzate, digitali e non.

Cancel
CHIUDI

Private area

Sign up
Do not remember your password?
Cancel Log in

Log in to restricted area

Cancel Log in

Registration

Notice on the treatment of personal data

Dear visitor, in the following sections we will describe how the reserved area of the www.ibi-lorenzini.it website is managed as far as processing personal data of users. The notice is issued pursuant to art. 13 of EU Regulation 679/2016 (hereinafter also the Regulation) on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and applies to those who interact with the website of Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. (hereinafter I.B.I.), which can be accessed at the following address: www.ibi-lorenzini.it, the opening page of the official I.B.I. website. The notice only applies to the I.B.I. website. It does not apply to any other websites that the user may access through links.

  1. The processing of the personal data that you supply, which are also used for the creation of your user profile, and which will be included in the “Doctors’ Details” database, has the following purposes:

  • carry out medical sales related activities for drugs for human consumption. Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. and Ibigen S.r.l., part of the same company group (hereinafter also Ibigen Group), carry out such activities in compliance with the provisions of the current regulations, with particular, but not exclusive, attention to Italian Legislative Decree no. 219 of 24.04.2006 and subsequent modifications. In view of the objectives of the Ibigen Group, it is important to point out that the processing activities do not deal with any special data. The supply of the data for the medical sales activities is necessary, and failure to provide consent will make it impossible for us to fulfil the above objectives;

  • forwarding of invitations or information on congresses, conferences, seminars, communications on initiatives promoted or sponsored by the Ibigen group, regular or occasional publications, information on new products, methods and services. Such activities are carried out by e-mail, fax, SMS, normal post or telephone. The supply of the data for such purposes is optional, and failure to supply them will result in the information not being forwarded.

  1. As far as the creation of your profile on our website, we remind you that your password is strictly confidential and should not be disclosed.
  2. Your data will not be disclosed, but may be shared with individuals, companies, associations or professional studios providing support or consultancy services to the Ibigen Group, the medical sales representative network, our suppliers and any sub-suppliers - from time to time entrusted with activities connected with the above objectives -, mailing or statistical survey companies, or companies for the forwarding of scientific documentation, and individuals authorised to access the data by law and/or pursuant to secondary regulations.
  3. Such people may only acquire knowledge of your personal data for the above mentioned purposes.
  4. The Owners of the Treatment (Data Controllers) are the two companies of the Ibigen Group with legal headquarters at Via Fossignano no. 2, Aprilia (LT), Italy.
  5. Personal data are processed using manual and automated means, for the time necessary for reaching the objectives for which they were collected. Special safety measures are in place to avoid data loss, unlawful or incorrect use and unauthorised access.
  6. Lastly, we also inform you that you can at any time exercise the rights contemplated by the Regulation, and in particular request access to the data, their correction, update and block, or you can withdraw your consent, or request the limitation of the processing or the cancellation of the data. As data subject, you also have the right to issue a complaint with the relevant control Authority. Such rights may be exercised in writing to the following e-mail address: info@ibi-lorenzini.com.
  7. The Data Protection Officer may be contacted at the following e-mail address: dpo_ibi@protectiontrade.it

* Required fields

Cancel
?>